WATS3D for the Detection of Esophageal Dysplasia

计划入组 160 人 · 首次发布于 2017 年 1 月 4 日

Clinical Utility of WATS3D: A 5-Year Prospective Study

计划入组 90,000 人 · 首次发布于 2020 年 3 月 18 日

The WATS3D (Wide Area Transepithelial Sample Biopsy With 3-Dimensional Computer-Assisted Analysis) U.S. Registry

计划入组 3,173 人 · 首次发布于 2016 年 12 月 12 日

test Sequence

Thin-Layer Rapid Use Epicutaneous Patch Test

Positive Skin Test Control-Histamine

Heart Test Laboratories

United States

Pop Test Oncology LLC

KLEEN TEST PRODUCTS CORPORATION

United States

CDx Diagnostics Receives FDA Breakthrough Device Designation for AI-Powered WATS3D Esophageal Cancer Diagnostic System

Illumina Secures Medicare Reimbursement for Comprehensive Cancer Genomic Test at $2,989 Per Test

OncoPrism-HNSCC Biomarker Test Shows Superior Predictive Accuracy for Head and Neck Cancer Immunotherapy